Literature DB >> 19560772

Endothelial activation, inflammation and premature atherosclerosis in children with familial dyslipidemia.

Ornella Guardamagna1, Francesca Abello, Paola Saracco, Viviana Baracco, Elio Rolfo, Matteo Pirro.   

Abstract

OBJECTIVES: Prospective studies demonstrated an increased cardiovascular risk in subjects with high levels of either the endothelial-platelet activation marker P-selectin or high-sensitivity C-reactive protein (hs-CRP). Both children with heterozygous familial hypercholesterolemia (FH) and those with familial combined hyperlipidemia (FCHL) are prone to premature atherosclerosis. Our objective was to investigate in children with either FH or FCHL whether P-selectin and hs-CRP contribute to carotid intima-media thickness (IMT), along with increased plasma lipid levels.
METHODS: Carotid IMT, serum lipids and soluble P-selectin and hs-CRP levels were measured in 88 children (mean age 10.5+/-4.3 years) including 44 dyslipidemic children (25 with FH and 19 with FCHL) and 44 non-dyslipidemic controls.
RESULTS: Carotid IMT was significantly higher among dyslipidemic than in control children (0.46+/-0.06mm vs 0.43+/-0.06mm, p=0.003) and serum P-selectin levels as well [129(50-254)ng/mL vs 50(24.5-130)ng/mL, p<0.001]. FH but not FCHL children had higher hs-CRP levels than controls [0.7(0.01-6.9)mg/L vs 0.3(0.1-1.2)mg/L, p=0.006]. In the entire sample of dyslipidemic children, carotid IMT was positively associated with soluble P-selectin levels (rho=0.30, p=0.049), but not with hs-CRP. The association between P-selectin and carotid IMT was independent from confounders, including plasma lipid levels.
CONCLUSION: Endothelial-platelet activation, more than low-grade systemic inflammation, correlates with premature atherosclerosis among children with familial dyslipidemia, this association being independent from plasma lipid levels.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19560772     DOI: 10.1016/j.atherosclerosis.2009.06.006

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  12 in total

Review 1.  Increased intima-media thickness of the carotid artery in childhood: a systematic review of observational studies.

Authors:  Christophe Lamotte; Catalina Iliescu; Christian Libersa; Frédéric Gottrand
Journal:  Eur J Pediatr       Date:  2010-10-27       Impact factor: 3.183

2.  Soluble P-selectin levels are associated with cardiovascular mortality and sudden cardiac death in male dialysis patients.

Authors:  Julia J Scialla; Laura C Plantinga; W H Linda Kao; Bernard Jaar; Neil R Powe; Rulan S Parekh
Journal:  Am J Nephrol       Date:  2011-02-23       Impact factor: 3.754

3.  Coronary insufficiency in children: Review of literature and report of a rare case with unknown aetiology.

Authors:  Ahmed A Arifi; Munir Ahmad; Ahmed Al Assal; Imad Naja; Hani K Najm
Journal:  J Saudi Heart Assoc       Date:  2010-02-24

4.  Soluble receptor and gene polymorphism for AGE: relationship with obesity and cardiovascular risks.

Authors:  Mohamed Rowisha; Manal El-Batch; Thanaa El Shikh; Salwa El Melegy; Hany Aly
Journal:  Pediatr Res       Date:  2016-03-18       Impact factor: 3.756

5.  Hyperleptinemia: implications on the inflammatory state and vascular protection in obese adolescents submitted to an interdisciplinary therapy.

Authors:  Priscila L Sanches; Marco T de Mello; Natália Elias; Francisco A H Fonseca; Raquel M S Campos; June Carnier; Aline de Piano; Deborah C L Masquio; Patrícia L Silva; Lila M Oyama; Flavia C Corgosinho; Cláudia M O Nascimento; Lian Tock; Carolina Ackel D'Elia; Sergio Tufik; Ana R Dâmaso
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

Review 6.  Role of colesevelam in managing heterozygous familial hypercholesterolemia in adolescents and children.

Authors:  Travis Sonnett; Jennifer Robinson; Paul Milani; R Keith Campbell
Journal:  Adolesc Health Med Ther       Date:  2010-08-04

7.  Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia.

Authors:  Mahtab Sharifi; Elizabeth Higginson; Sven Bos; Angela Gallivan; Darren Harvey; Ka Wah Li; Amali Abeysekera; Angela Haddon; Helen Ashby; Kate E Shipman; Jackie A Cooper; Marta Futema; Jeanine E Roeters van Lennep; Eric J G Sijbrands; Mourad Labib; Devaki Nair; Steve E Humphries
Journal:  Atherosclerosis       Date:  2017-05-13       Impact factor: 5.162

8.  "Apple does not fall far from the tree" - subclinical atherosclerosis in children with familial hypercholesterolemia.

Authors:  Michał Podgórski; Katarzyna Szatko; Małgorzata Stańczyk; Monika Pawlak-Bratkowska; Agnieszka Konopka; Ewa Starostecka; Marcin Tkaczyk; Sebastian Góreczny; Lena Rutkowska; Agnieszka Gach; Maciej Łukaszewski; Piotr Grzelak; Maciej Banach
Journal:  Lipids Health Dis       Date:  2020-07-14       Impact factor: 3.876

Review 9.  Cardiovascular risk stratification in familial hypercholesterolaemia.

Authors:  Mahtab Sharifi; Roby D Rakhit; Steve E Humphries; Devaki Nair
Journal:  Heart       Date:  2016-04-28       Impact factor: 5.994

10.  Enhanced status of inflammation and endothelial activation in subjects with familial hypercholesterolaemia and their related unaffected family members: a case control study.

Authors:  Thuhairah Rahman; Nur Suhana Hamzan; Atiqah Mokhsin; Radzi Rahmat; Zubin Othman Ibrahim; Rafezah Razali; Malathi Thevarajah; Hapizah Nawawi
Journal:  Lipids Health Dis       Date:  2017-04-24       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.